Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valaciclovir for inter-appointment endodontic pain in necrotic single-rooted teeth with symptomatic apical periodontitis
IRCT20240906062957N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in apical periodontitis (AP) and pulpal necrosis comparing Valaciclovir with Placebo (2 arms). Primary endpoint: Inter-appointment endodontic pain intensity. Started Oct 2024; status: completed.
02
Drugs
valaciclovir
03
Conditions
apical periodontitis (AP)pulpal necrosis
Beyond the preview
Go deeper on IRCT20240906062957N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240906062957N1.